Adherium Limited announced that Rick Legleiter has tendered his resignation as chief executive officer, and has provided six months' notice to enable a smooth transition to new leadership. Mr. Legleiter joined the business in May 2021 during the height of the COVID-19 pandemic. Since that time, he has led successful regulatory filings, next generation product launches and a focus on a go-to-market strategy leading to multiple agreements with major US commercial partners.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 AUD | +11.11% |
|
+11.11% | -64.29% |
May. 24 | Adherium Partners with AstraZeneca for Hailie Smartinhaler Trial | MT |
May. 23 | Adherium Raises Nearly AU$7 Million from Entitlement Offer | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-64.29% | 8.87M | |
+1.15% | 205B | |
+4.69% | 179B | |
+31.83% | 158B | |
+33.39% | 113B | |
+2.81% | 64.93B | |
+22.99% | 56.51B | |
-4.03% | 46.36B | |
-8.60% | 37.07B | |
+2.35% | 36.12B |
- Stock Market
- Equities
- ADR Stock
- News Adherium Limited
- Adherium Limited Announces Resignation of Rick Legleiter as Chief Executive Officer